Intravenous Lidocaine: Old-School Drug, New Purpose—Reduction of Intractable Pain in Patients with Chemotherapy Induced Peripheral Neuropathy
Background. Treatment of intractable pain due to chemotherapy induced peripheral neuropathy (CIPN) is a challenge. Intravenous (iv) lidocaine has shown to be a treatment option for neuropathic pain of different etiologies. Methods. Lidocaine (1.5 mg/kg in 10 minutes followed by 1.5 mg/kg/h over 5 ho...
Saved in:
Main Authors: | Sandra A. S. van den Heuvel, Selina E. I. van der Wal, Lotte A. Smedes, Sandra A. Radema, Nens van Alfen, Kris C. P. Vissers, Monique A. H. Steegers |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Pain Research and Management |
Online Access: | http://dx.doi.org/10.1155/2017/8053474 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Determining postoperative benefits of intravenous lidocaine and esketamine following thyroidectomy
by: Dan-Feng Wang, et al.
Published: (2024-09-01) -
Reply to ‘Determining postoperative benefits of intravenous lidocaine and esketamine following thyroidectomy’
by: Mengci Li, et al.
Published: (2024-09-01) -
Intravenous γ Globulin for Intractable Abdominal Pain due to IgA Vasculitis
by: George Naifa, et al.
Published: (2020-01-01) -
The Effects of Preoperative Oral Pregabalin and Perioperative Intravenous Lidocaine Infusion on Postoperative Morphine Requirement in Patients Undergoing Laparatomy
by: Senniye Ulgen Zengin, et al.
Published: (2015-01-01) -
A Randomized Trial of Topical Anesthesia Comparing Lidocaine Versus Lidocaine Plus Xylometazoline for Unsedated Transnasal Upper Gastrointestinal Endoscopy
by: Justin Cheung, et al.
Published: (2010-01-01)